← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2001Last known activity
Oct 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT03265171CollaboratorN/A—
- NCT05317806Lead sponsorPhase 4Oct 31, 2022
- NCT05317806Reponsible party - principal investigatorPhase 4Oct 31, 2022
- NCT04567511Reponsible party - principal investigatorPhase 4Mar 31, 2021
- NCT04567511Lead sponsorPhase 4Mar 31, 2021
- NCT04567511Overall official - principal investigatorPhase 4Mar 31, 2021
- NCT03921294Overall official - principal investigatorPhase 4May 31, 2019
- NCT03921294Reponsible party - principal investigatorPhase 4May 31, 2019
- NCT03921294Lead sponsorPhase 4May 31, 2019
- NCT02690714Overall official - principal investigatorPhase 2/Phase 3May 4, 2016
- NCT00157105Overall official - principal investigatorN/AFeb 1, 2001
Details
- Last known activity
- Oct 31, 2022